Homology Medicines, Inc.·4

Feb 28, 4:06 PM ET

Smith W Bradford 4

4 · Homology Medicines, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-24
Smith W Bradford
CFO, Treasurer & Secretary
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-24+126,000126,000 total
    Exercise: $2.71Exp: 2032-02-24Common Stock (126,000 underlying)
  • Award

    Restricted Stock Units

    2022-02-24+21,00021,000 total
    Common Stock (21,000 underlying)
Footnotes (3)
  • [F1]The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
  • [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION